Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.210
-0.010 (-0.82%)
Oct 30, 2026, 4:00 PM EDT - Market closed

Alzamend Neuro Ratios and Metrics

Millions USD. Fiscal year is May - Apr.

Total Valuation

Fiscal Quarter
CurrentQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Oct '26 Jul '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21
6648107467356114453641128595136186
Market Cap Growth (YoY)
-37.43%-3.68%-0.56%32.55%36.89%117.00%-10.66%8.59%-37.90%-93.16%-90.80%-91.13%-89.87%-48.27%-44.08%-52.92%-39.92%-77.51%---
Enterprise Value
-262443126355103946551007183123171
Last Close Price
1.211.311.142.152.532.255.9410.2214.1332.1363.9977.40157.57611.55738.85895.991579.501200.281377.002065.502889.00

Price Ratios

Fiscal Quarter
CurrentQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Oct '26 Jul '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21
PB Ratio
1.011.085.923.742.201.221.101.791.87-2.48-1.88-1.50-4.22-389.0217.4210.9212.717.597.1111.3614.28
P/TBV Ratio
1.011.085.923.742.201.221.101.791.87-----17.4210.9212.717.597.1111.3614.28

Financial Efficiency

Fiscal Quarter
CurrentQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Oct '26 Jul '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21
Debt / Equity Ratio
-----------0.12---------0.03
Net Debt / Equity Ratio
-1.31-1.31-0.97-1.24-1.02-1.05-0.99-0.97-1.090.990.030.080.0815.02-1.69-1.26-1.04-1.03-1.05-0.99-1.02
Net Debt / EBITDA Ratio
0.850.850.080.390.770.910.890.810.710.160.010.020.010.110.35---1.14--
Net Debt / FCF Ratio
1.111.110.090.440.760.700.570.450.510.200.010.030.020.170.580.881.101.442.091.872.48
Quick Ratio
2.772.770.531.466.205.726.224.633.260.410.120.070.060.621.792.795.6111.2212.0725.259.21
Current Ratio
3.013.011.311.996.586.036.585.443.800.490.140.160.210.882.033.196.3111.7812.3726.629.83
Return on Equity (ROE)
-163.23%-163.23%-373.18%-249.97%-144.76%-302.25%-657.17%--1092.96%--4408.31%-1196.26%-496.81%-277.69%-181.47%-173.29%-115.43%-98.61%-160.92%-182.81%-
Return on Assets (ROA)
-76.44%-76.44%-163.99%-107.01%-72.71%-97.46%-107.38%-106.08%-121.64%-214.47%-189.73%-166.84%-166.06%-129.40%-90.97%-92.20%-63.04%-56.19%-88.35%-91.33%-
Return on Capital Employed (ROCE)
-156.70%-156.70%-1195.70%-322.00%-134.30%-116.70%-113.30%-122.00%-155.40%608.30%383.10%407.10%565.00%13607.80%-488.30%-263.50%-143.10%-116.70%-92.30%-80.80%-63.20%

Yields

Fiscal Quarter
CurrentQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Oct '26 Jul '26 Apr '26 Jan '26 Oct '25 Jul '25 Apr '25 Jan '25 Oct '24 Jul '24 Apr '24 Jan '24 Oct '23 Jul '23 Apr '23 Jan '23 Oct '22 Jul '22 Apr '22 Jan '22 Oct '21
Earnings Yield
-191.28%-144.92%-202.25%-86.16%-61.16%-95.80%-103.51%-68.55%-83.26%-246.21%-203.75%-218.40%-134.03%-35.00%-28.04%-24.13%-11.27%-15.41%-13.03%-7.17%-4.46%
FCF Yield
-117.20%-109.03%-186.01%-75.48%-60.89%-124.06%-157.47%-119.95%-113.92%-203.70%-172.40%-162.47%-79.55%-22.39%-16.82%-13.06%-7.46%-9.46%-7.08%-4.64%-2.87%
Buyback Yield / Dilution
-311.13%-311.13%-640.27%-765.27%-985.74%-1121.34%-499.67%-293.71%-118.23%-8.09%-4.07%-4.79%-4.52%-5.89%-9.45%-11.38%-16.34%-21.90%-22.64%-18.56%-12.05%
SEC Filings: 10-K · 10-Q